Latest News


CyDex gets FDA approval of in-house drug

American City Business Journals | 1 hour 49 minutes ago

CyDex Pharmaceuticals said Monday that it has achieved a company first: federal approval of a drug it developed in-house.... (more)


ConMed Struck Down By Dollar Gain - Forbes.com

Forbes | 4 hours 29 minutes ago

ConMed was already wounded last year by penny-pinching hospital administrators, but what really scarred the maker of minimally invasive surgical equipment was the unexpected revival of the dollar in the fourth quarter.... (more)


Sector Snap: Medical technology shares slide - Forbes.com

Forbes | 4 hours 29 minutes ago

Shares of medical technology companies mostly traded lower Monday after an Oppenheimer analyst predicted hospitals will cut their spending by 15 percent to 25 percent in 2009, and reduced his estimates on a half dozen companies.... (more)


Northstar Neuroscience will close, distribute cash to stockholders

Seattle Times, The | 7 hours 51 minutes ago

Northstar Neuroscience, whose technology for treating stroke patients failed a clinical trial last January, said Monday it plans to lay off most of its remaining employees and seek shareholder permission to liquidate the company.... (more)


Wireless video co Amimon wins deal with Stryker

Globes (Israel) | 8 hours 57 minutes ago

Wireless high definition video connectivity firm has signed an exclusive deal with medical device giant Stryker which allows Stryker to use Amimon technology in medical endoscopy. ... (more)


Teleflex may grow in Triangle as it shifts focus

American City Business Journals | 21 hours 9 minutes ago

DURHAM – Teleflex Inc. executives are taking steps toward expanding the company’s medical division headquarters in Durham – a move that could bring about 200 jobs to the Triangle in 2009.... (more)


Labopharm's chronic pain drug Ryzolt receives US FDA approval

Pharmabiz.com (India) | 21 hours 42 minutes ago

Labopharm Inc announced that Ryzolt (tramadol HCl extended release tablets), Labopharm's once-daily formulation of the analgesic tramadol, has been approved by the US Food and Drug Administration (FDA). Ryzolt is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.... (more)


Boston Scientific has some properties on market

Boston Globe, The | 3 days 19 hours 38 minutes ago

Boston Scientific Corp., once a key growth engine in the suburbs west of Boston, is shrinking its footprint.... (more)




 1  

9 Stories  |   RSS Feed



Sign up for AdvaMed SmartBrief



Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more

Latest Blog Postsview more


Companies in the news